TISSUE INTERACTION IN THE DEVELOPMENT OF THYMUS LYMPHOCYTES

by Owen, J. J. T., Ritter, M. A.
Published 1969

Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).

by Tungekar, M. F., Gatter, K. C., Ritter, M. A.
Published 1996

Functional Analysis of the Thymic Microenvironment Using Recombinant Single Chain Antibodies

by Palmer, D. B., Solomou, A., Ritter, M. A.
Published 2000

Immunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies.

by Sivolapenko, G. B., Kanariou, M., Edwards, R. J., Epenetos, A. A., Ritter, M. A.
Published 1989

Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjug...

by Sivolapenko, G. B., Moreno, C., Smith, W., Corválan, J., Ritter, M. A., Epenetos, A. A.
Published 1991

Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast.

by al-Tubuly, A. A., Luqmani, Y. A., Shousha, S., Melcher, D., Ritter, M. A.
Published 1996

Identification of glioma-associated antigen MUC 2-63 as CD44.

by Romeijn, P., Lenthall, R., Stavrou, D., Melcher, D., Ladyman, H., Ritter, M. A.
Published 1994

The role of the posterior cruciate ligament in total knee replacement

by Ritter, M. A., Davis, K. E., Meding, J. B., Farris, A.
Published 2012

Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

by Al Jabaari, B., Ladyman, H. M., Larché, M., Sivolapenko, G. B., Epenetos, A. A., Ritter, M. A.
Published 1989

Micromotion at the tibial plateau in primary and revision total knee arthroplasty: fixed versus rotating platform designs

by Small, S. R., Rogge, R. D., Malinzak, R. A., Reyes, E. M., Cook, P. L., Farley, K. A., Ritter, M. A.
Published 2016